Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Humanigen’s lenzilumab improves survival in hospitalised Covid-19 patients

pharmaceutical-technologyMarch 30, 2021

Tag: Humanigen , lenzilumab , COVID-19

PharmaSources Customer Service